, ,
Presentations this author is a contributor to:
Exploiting the type-1 interferon pathway as a biomarker and therapeutic target for metastatic cancer (#S-20)
9:30 AM
Belinda Parker
Plenary Session 2 Cytokines and interferons in cancer